Inventor · disambiguated record
Robert Alonso
Also filed as: ALONSO ROBERT
18 granted patents·13 pending applications·38 citations·filing 2005–2023
92Inventor score
Files withALONSO ROBERT10MITOCHON PHARMACEUTICALS INC8ACTELION PHARMACEUTICALS LTD4PEDICIS RES LLC4YAUPON THERAPEUTICS INC2
Top patents by PatentIndex Score
31 records- 0190US9974755B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2016·Granted May 22, 2018·9 cites·21 claims
- 0288US10864173B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2019·Granted Dec 15, 2020·2 cites·19 claims
- 0386US10220006B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of Neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2017·Granted Mar 5, 2019·4 cites·26 claims
- 0483US11504384B1Compositions and methods for treatment of skin infectionsPEDICIS RES LLC·Filed 2022·Granted Nov 22, 2022·1 cites·15 claims
- 0583US9763896B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS LLC·Filed 2016·Granted Sep 19, 2017·5 cites·12 claims
- 0683US7838564B2Stabilized compositions of volatile alkylating agents and methods of using thereofYAUPON THERAPEUTICS INC·Filed 2009·Granted Nov 23, 2010·5 cites·7 claims
- 0783US2024156750A1Induced Expression of Brain Derived Neurotrophic Factor (BDNF) for Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental and/or Metabolic DiseasesMITOCHON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0881US8664278B2Stabilized compositions of volatile alkylating agents and methods of using thereofACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Mar 4, 2014·3 cites·23 claims
- 0979US7872050B2Stabilized compositions of volatile alkylating agents and methods of using thereofYAUPON THERAPEUTICS INC·Filed 2006·Granted Jan 18, 2011·3 cites·14 claims
- 1073US11833161B2Compositions and methods for treatment of skin infectionsPEDICIS RES LLC·Filed 2022·Granted Dec 5, 2023·0 cites·15 claims
- 1173US11717497B2Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2020·Granted Aug 8, 2023·0 cites·23 claims
- 1273US8501817B2Stabilized compositions of alkylating agents and methods of using sameALONSO ROBERT·Filed 2009·Granted Aug 6, 2013·2 cites·11 claims
- 1373US8450375B2Stabilized compositions of volatile alkylating agents and methods of using thereofALONSO ROBERT·Filed 2006·Granted May 28, 2013·1 cites·9 claims
- 1472US10548900B2DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2017·Granted Feb 4, 2020·1 cites·21 claims
- 1572US8501819B2Stabilized compositions of volatile alkylating agents and methods of using thereofALONSO ROBERT·Filed 2010·Granted Aug 6, 2013·1 cites·10 claims
- 1670US2023100940A1DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic DiseasesMITOCHON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1768US8501818B2Stabilized compositions of alkylating agents and methods of using sameALONSO ROBERT·Filed 2010·Granted Aug 6, 2013·1 cites·24 claims
- 1865US9382191B2Stabilized compositions of volatile alkylating agents and methods of using thereofACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Jul 5, 2016·0 cites·18 claims
- 1965US2018092931A1Compositions and methods for treatment of skin infectionsPEDICIS RES LLC·Filed 2017·Application pending·0 cites
- 2064US11406642B2DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseasesMITOCHON PHARMACEUTICALS INC·Filed 2019·Granted Aug 9, 2022·0 cites·16 claims
- 2162US2019142848A1Compositions and methods for treatment of skin infectionsPEDICIS RES LLC·Filed 2018·Application pending·0 cites
- 2261US2014155491A1Stabilized Compositions of Volatile Alkylating Agents and Methods of Using ThereofALONSO ROBERT·Filed 2013·Application pending·0 cites
- 2357US10744174B1Composition(s) and method(s) for topically treating painALONSO ROBERT·Filed 2017·Granted Aug 18, 2020·0 cites·11 claims
- 2455US2021038669A1Composition(s) for Topically Treating PainALONSO ROBERT·Filed 2020·Application pending·0 cites
- 2551US2006009468A1Method for treatment of cancerCROOKS PETER A·Filed 2005·Application pending·0 cites
- 2650US2014187810A1Stabilized compositions of alkylating agents and methods of using sameACTELION PHARMACEUTICALS LTD·Filed 2013·Application pending·0 cites
- 2748US2014142193A1Stabilized Compositions Of Alkylating Agents And Methods Of Using SameACTELION PHARMACEUTICALS LTD·Filed 2013·Application pending·0 cites
- 2847US2013184243A1Compositions of alkylating agents and methods of treating skin disorders therewithALONSO ROBERT·Filed 2012·Application pending·0 cites
- 2947US2014271529A1Antifungal compositions for the treatment of secondary skin and nail infectionsALC THERAPEUTICS LLC·Filed 2014·Application pending·0 cites
- 3046US2012157545A1Methods for treating skin disorders with topical nitrogen mustard compositionsALONSO ROBERT·Filed 2011·Application pending·0 cites
- 3136US2011039943A1Methods for treating skin disorders with topical nitrogen mustard compositionsALONSO ROBERT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Alonso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →